Free Newsletter
Oklahoma professors unveil new approach to cancer therapy
A pair of scientists at the University of Oklahoma say they have developed a fusion protein that can prevent the spread of cancer. The fusion protein blocks cancer cells from ingesting methionine, a protein they need to develop. The researchers have developed a mechanism that delivers the compound directly to cancer cells, avoiding any damage to healthy cells. The research fits into a broad range of programs looking to develop new ways to deliver cancer therapies without harming healthy cells, avoiding harsh side effects linked to chemotherapy. While the professors say they have started with breast cancer research, the same approach should work in a broad array of solid tumor cancers. They expect to conduct another round of animal tests before entering the clinic.
- here's the AP report on the cancer program
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: